Senseonics Holdings, Inc. (SENS) News

Senseonics Holdings, Inc. (SENS): $0.38

0.01 (-2.56%)

POWR Rating

Component Grades

Momentum

F

Stability

D

Sentiment

Quality

D

Filter SENS News Items

SENS News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

Latest SENS News From Around the Web

Below are the latest news stories about SENSEONICS HOLDINGS INC that investors may wish to consider to help them evaluate SENS as an investment opportunity.

Senseonics Holdings, Inc. (AMEX:SENS) Q3 2023 Earnings Call Transcript

Senseonics Holdings, Inc. (AMEX:SENS) Q3 2023 Earnings Call Transcript November 9, 2023 Senseonics Holdings, Inc. reports earnings inline with expectations. Reported EPS is $-0.04 EPS, expectations were $-0.04. Operator: Good day and welcome to the Senseonics Third Quarter 2023 Earnings Conference Call. All participants will be in listen-only mode. [Operator Instructions] Please note today’s event […]

Yahoo | November 10, 2023

Q3 2023 Senseonics Holdings Inc Earnings Call

Q3 2023 Senseonics Holdings Inc Earnings Call

Yahoo | November 10, 2023

Senseonics Holdings, Inc. Reports Third Quarter 2023 Financial Results

GERMANTOWN, Md., November 09, 2023--Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today reported financial results for the quarter ended September 30, 2023.

Yahoo | November 9, 2023

Senseonics Holdings, Inc. to Participate in the Stifel 2023 Healthcare Conference

GERMANTOWN, Md., November 09, 2023--Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced plans to participate in the upcoming Stifel 2023 Healthcare Conference, taking place in New York, NY.

Yahoo | November 9, 2023

Phreesia (PHR) Surges 10.3%: Is This an Indication of Further Gains?

Phreesia (PHR) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

Yahoo | November 1, 2023

Senseonics Holdings, Inc Schedules Third Quarter 2023 Earnings Release and Conference Call for November 9, 2023 at 4:30 p.m. Eastern Time

GERMANTOWN, Md., October 30, 2023--Senseonics Holdings, Inc. (NYSE-American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced that it plans to release its third quarter 2023 financial results after market close on Thursday, November 9, 2023.

Yahoo | October 30, 2023

Ascensia Diabetes Care and Senseonics Announce ‘The CGM for Real Life’ Campaign to Raise Awareness of How Long-Term Eversense E3 Empowers People with Diabetes

PARSIPPANY, N.J. & GERMANTOWN, Md., October 09, 2023--Ascensia Diabetes Care, a global diabetes care company, and Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, have launched a new U.S. advertising and marketing campaign for Eversense® E3 CGM System. ‘The CGM for Real Life’ campaign is designed to significantly drive awareness

Yahoo | October 9, 2023

Senseonics Announces the Last Patient Completion of the 365-Day ENHANCE Pivotal Clinical Study

GERMANTOWN, Md., September 26, 2023--Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced the completion of the ENHANCE Pivotal Clinical Study adult cohort following the recently completed 365-day visit for the final study patient.

Yahoo | September 26, 2023

Senseonics Holdings, Inc. to Participate in the Gilmartin Group Emerging Growth Company Showcase

GERMANTOWN, Md., September 14, 2023--Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced plans to participate in the upcoming Gilmartin Group Emerging Growth Company Showcase, taking place virtually.

Yahoo | September 14, 2023

Senseonics Holdings, Inc. Enters Into $50 Million Loan Facility With Hercules Capital

GERMANTOWN, Md., September 11, 2023--Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced that it has entered into a $50 million loan facility with Hercules Capital, Inc. (NYSE: HTGC) ("Hercules"). The company also announced it drew down $25 million upon the transaction closing.

Yahoo | September 11, 2023


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!